← Back to all trials
Recruiting
NCT06762379
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
Conditions: Metastatic Prostate Cancer (mPC)
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 125
Sponsor: European Institute of Oncology
Location: European Institute of oncology Milan Italy
Summary
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
Eligibility Criteria
Inclusion Criteria:
* Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
Exclusion Criteria:
* Unable to provide written informed consent
Source: ClinicalTrials.gov (NCT06762379). StuddyBuddy aggregates publicly available trial information.
